Psychological and pharmacological treatments of bulimia nervosa: a research update |
| |
| Institution: | 1. Translational Research Center, University Hospital of Psychiatry, University of Bern, Switzerland;2. Psychiatric Center GGz Centraal, Amersfoort, The Netherlands; Department of Psychiatry, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, the Netherlands;3. School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland;4. Department of Psychiatry, Complejo Hospitalario de Navarra, Spain. Instituto de Investigación Sanitaria de Navarra (IdisNa), Spain;5. Mental Health Department, Servicio Navarro de Salud, Pamplona, Spain, Navarra Institute for Health Research, IdiSNA, Pamplona, Spain;6. Institut de Psychiatrie et Neurosciences de Paris, INSERM U1266, Université de Paris, Paris, France;7. ICube - CNRS UMR 7357, Neurophysiology, FMTS, University of Strasbourg, Strasbourg, France;8. CEMNIS - Noninvasive Neuromodulation Center, University Hospital Strasbourg, Strasbourg, France;9. Department of Neuroscience (DNS), University of Padova, Padova, Italy;10. Padova Neuroscience Center, University of Padova, Padua, Italy;11. Department of Psychiatry, University Psychiatric Center Duffel, Duffel, Belgium;12. Department of Psychiatry, Collaborative Antwerp Psychiatric Research Institute (CAPRI), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium;13. Center for Psychosocial Medicine, Department of General Psychiatry, Heidelberg University, Heidelberg, Germany;14. Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany;1. School of Psychology, Australian Catholic University, 115 Victoria Parade/Locked Bag 4115, Melbourne, Victoria 3065, Australia;2. Oxford University, Department of Psychiatry, Warneford Hospital, Oxford OX3 7JX, UK;3. Department of Psychiatry, Washington University School of Medicine, Mailstop 8134-29-2100, 660 S. Euclid Ave, St. Louis, MO 63110, United States |
| |
| Abstract: | Bulimia nervosa (BN) is an eating disorder, primarily afflicting young women, which can be successfully treated. The two most intensively researched treatments for BN have been antidepressant medication and cognitive-behavior therapy (CBT). Controlled studies of the separate and combined effects of these methods are critically reviewed, and the theoretical and clinical implications of their findings discussed. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
